Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Some AIDS Drugs Promote Neurological Damage

07.10.2004


One group of drugs that is effective in fighting HIV may, paradoxically, also be promoting the death of sensory nerves in the skin, according to a study presented October 5, 2004, at the 129th annual meeting of the American Neurological Association in Toronto.



A team of American and Australian researchers reported that the use of certain anti-HIV drugs, called dideoxynucleosides, is highly correlated with a condition called sensory neuropathy, in which patients experience constant pain, and abnormal sensations including numbness and sensitivity, in the feet and legs. In a separate presentation, presented on October 4, the same investigators showed that simple punch skin biopsies are an effective way of identifying sensory neuropathy, possibly even before symptoms appear.

Dideoxynucleosides, members of a class of drugs called ’nucleoside reverse transcriptase inhibitors’ are common component of highly active antiretroviral therapy (HAART), the so-called AIDS "cocktails" that prevent HIV from duplicating itself. The authors noted that these drugs are frequently included in the generic HAART combinations used in Africa and India. "Because the introduction of HAART has reduced the rates of HIV-associated dementia and opportunistic infections, sensory neuropathies have become the commonest neurological disorders associated with AIDS," said lead author Justin C. McArthur, MD, of Johns Hopkins University in Baltimore, Maryland.


The factors that lead to HIV-associated sensory neuropathy are not clear. Diabetes, intravenous drug use, or hepatitis C may contribute to heightened susceptibility, along with some of the same drugs that help protect against HIV.

In the present study, McArthur and his colleagues at Johns Hopkins and at the Alfred Hospital, Burnet Institute, and Monash University in Melbourne, Australia studied the relationship between the use of three dideoxynucleosides called ddC, ddI, and d4T and the occurrence of sensory neuropathy. The researchers combined data from two diverse study populations in Baltimore and Melbourne, with significant (and preplanned) differences in terms of racial demographics and history of IV drug use, male homosexual relations, and hepatitis C co-infection. "We found a strong association between previous or current use of ddC, ddI, or d4T and the presence of symptomatic sensory neuropathy," said McArthur.

In a separate study in the same subjects, led by medical student Siva P. Raman, McArthur’s team used skin biopsies to determine whether the extent of HIV-sensory neuropathy was associated with a loss of the smallest sensory fibers in the skin, which are responsible for transmitting pain sensations. This method has been proposed as a way to measure the extent of sensory neuropathy and also to detect nerve damage that has not reached the stage where it causes pain or numbness.

Raman, McArthur, and colleagues found that the biopsy method correlates well with the extent of sensory neuropathy, and they were also able to detect nerve abnormalities in a substantial number of HIV patients who had not yet developed sensory neuropathy. They also showed that factors such as hepatitis C co-infection or vitamin B-12 deficiency, among others, were not apparently associated with the loss of small nerve fibers in the skin.

[abstracts]
323. Antiretroviral Exposure Is a Risk Factor for HIV-Associated Sensory Neuropathies, Justin C. McArthur, Jason Creighton, Richard Skolasky, Luxmi Lal, Richard Moore, Steven Wesselingh, and Katherine Cherry; Baltimore, MD and Melbourne, Victoria, Australia

Background: specific reverse transcriptase inhibitors may provoke HIV-associated sensory neuropathies (SN). Methods: 156 HIV+ adults underwent standardized clinical/physiological assessments. PGP9.5 immunostaining quantified epidermal innervation. Antiretroviral exposure was assessed with multivariate analysis.

Results: at JHU, 86% were black, 35% had a history of IDU, and 71% were HepC+. At MU, 95% were white, 92% had a history of MSM, and 11% were HepC+. HgbA1C levels were > 5.8% in 23% at JHU and 12% at MU (p=0.101). 33% were neuropathy-free, 18% had asymptomatic SN, and 49% symptomatic SN. The likelihood of having symptomatic SN was strongly associated with use of ddI (OR=2.6, p=.024), or d4T (OR=5.1, p=.002). Thermal and vibration thresholds were measured with the Case IV device and vibratory QST was relatively insensitive to symptomatic SN. More morphological abnormalities on skin biopsy were noted in SN subjects, but 23% of neuropathy-free had abnormalities. Conclusions: The frequency of SN was high and correlated strongly with anytime exposure to ddI or d4T. Hepatitis C serostatus did NOT modify the prevalence of SN at baseline. Morphological abnormalities were noted in a high proportion of neuropathy-free subjects. Quantitative sensory testing had a low diagnostic efficiency in this cohort. Study supported by NS44807

WIP4. HIV-associated sensory neuropathies: Relationship to epidermal nerve fiber densities

Siva P Raman, J Creighton, R Skolasky, TBN Cherry, R Moore, Carter K, S Wesselingh, C Cherry, JC McArthur. Baltimore, MD, USA, Melbourne, Australia.

Background: Specific nucleoside reverse transcriptase inhibitors (ddI, d4T, and ddC) provoke symptomatic HIV-associated sensory neuropathies (HIV-SN). The relationship of epidermal nerve fiber densities (ENFD) to symptoms of sensory neuropathy, and the modifying role of hepatitis C, Vitamin B12, HgbA1C, and lactate is uncertain.

Methods: 130 HIV-infected adults underwent standardized clinical and physiological assessment: skin biopsies and assays for hepatitis C (HpC), vitamin B12, hemoglobin A1C, and plasma lactate. Results: At baseline, HAART was used in 79% at JHU, and 90% at MU, with ddI and d4T used together in combination in 4% and 15% respectively. ENFD were calculated for 36 JHU subjects at the distal leg and thigh. The distribution of subjects was (JHU): neuropathy-free 30%; asymptomatic SN (asx-SN) 17%; and symptomatic SN (sx-SN) 52%. The average fiber density (distal leg and thigh) for sx-SN was 5.88, 9.38 for the neuropathy-free group, and 7.41 for the asx-SN, with a significant difference between the groups (p=0.01). There was no correlation between ENFD and Vitamin B12, lactate, Hepatitis C serostatus, or Hemoglobin A1C. Conclusions: ENFD are related to the expression of symptomatic SN, but do not appear to be modified by Hepatitis C, vitamin B12, lactate, and hemoglobin A1C, which are not correlated with fiber densities.

| newswise
Further information:
http://www.aneuroa.org

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>